Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 724 participants.
Also called NCT07762547
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 724 participants
- Sponsor
- Registry
-
NCT07762547
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07762547. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2030-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
- Acronym
- MOUNT-EASE
- Condition
- Moyamoya Disease
- Condition
- Moyamoya Syndrome
- Condition
- Aspirin
- Condition
- Remote Ischemic Conditioning
- Intervention (Drug)
- aspirin treatment
- Intervention (Drug)
- Aspirin placebo
- Intervention (Device)
- Remote Ischemic Conditioning
- Intervention (Device)
- Sham remote ischemic conditioning
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07762547- Content hash
c814ff17c119b5473fd44ed027ecd346923b2ccae66f067cfb813d5143f48152